Keywords: genmab/gsk, humax, cd20, deal, gets, ftc, ok

Genmab/GSK HuMax CD20 deal gets FTC OK

Article | 12 February 2007

Print This

Danish biotechnology company Genmab AS says that the worldwide agreement with UK-based drug major GlaxoSmithKline, which is focused on the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in